A cross-over, randomised feasibility study of digitally-printed versus hand-painted artificial eyes in adults: PERSONAL-EYE-S.


Journal

Eye (London, England)
ISSN: 1476-5454
Titre abrégé: Eye (Lond)
Pays: England
ID NLM: 8703986

Informations de publication

Date de publication:
02 Aug 2024
Historique:
received: 12 09 2023
accepted: 22 07 2024
revised: 03 07 2024
medline: 3 8 2024
pubmed: 3 8 2024
entrez: 2 8 2024
Statut: aheadofprint

Résumé

Over 60,000 patients in the United Kingdom are estimated to have artificial eyes. Manufacturing and hand-painting of artificial eyes have not changed significantly since 1948. Delays and colour-matching issues may severely impact a patient's rehabilitation pathway. Technology advances mean alternatives are now possible. This cross-over, randomised feasibility trial aimed to determine the feasibility of conducting a full-scale trial of the effectiveness and cost-effectiveness of digitally-printed artificial eyes compared to hand-painted. Patients aged ≥18 years who were longstanding artificial eye users requiring a replacement were randomised to receive either a hand-painted or digitally-printed eye first followed by the other type of eye. Participants were asked to approach a close contact (CC) willing to participate alongside them. A subset of participants, their CCs, and staff were interviewed about their opinions on trial procedures, artificial eyes, delivery times and satisfaction. Thirty-five participants were randomised and 10 CCs consented. Participant retention at final follow-up was 85.7%. Outcome data completion rates ranged from 91-100%. EQ-5D-5L completion ranged from 83-97%. Resource-use completion ranged from 0-94% with total costs at £347 for hand-painted and £404 for digitally-printed eye. There were two adverse events. Twelve participants, five CCs, and five staff were interviewed. There were positive and negative features of both types of eyes. We identified that social and psychological wellbeing is affected, often for many years after eye removal. Participation in the feasibility study was well accepted. The feasibility study outcomes indicate that a full trial is achievable. ISRCTN85921622.

Sections du résumé

BACKGROUND/OBJECTIVES OBJECTIVE
Over 60,000 patients in the United Kingdom are estimated to have artificial eyes. Manufacturing and hand-painting of artificial eyes have not changed significantly since 1948. Delays and colour-matching issues may severely impact a patient's rehabilitation pathway. Technology advances mean alternatives are now possible. This cross-over, randomised feasibility trial aimed to determine the feasibility of conducting a full-scale trial of the effectiveness and cost-effectiveness of digitally-printed artificial eyes compared to hand-painted.
SUBJECTS/METHODS METHODS
Patients aged ≥18 years who were longstanding artificial eye users requiring a replacement were randomised to receive either a hand-painted or digitally-printed eye first followed by the other type of eye. Participants were asked to approach a close contact (CC) willing to participate alongside them. A subset of participants, their CCs, and staff were interviewed about their opinions on trial procedures, artificial eyes, delivery times and satisfaction.
RESULTS RESULTS
Thirty-five participants were randomised and 10 CCs consented. Participant retention at final follow-up was 85.7%. Outcome data completion rates ranged from 91-100%. EQ-5D-5L completion ranged from 83-97%. Resource-use completion ranged from 0-94% with total costs at £347 for hand-painted and £404 for digitally-printed eye. There were two adverse events. Twelve participants, five CCs, and five staff were interviewed. There were positive and negative features of both types of eyes. We identified that social and psychological wellbeing is affected, often for many years after eye removal. Participation in the feasibility study was well accepted.
CONCLUSIONS CONCLUSIONS
The feasibility study outcomes indicate that a full trial is achievable.
TRIAL REGISTRATION NUMBER BACKGROUND
ISRCTN85921622.

Identifiants

pubmed: 39095468
doi: 10.1038/s41433-024-03273-0
pii: 10.1038/s41433-024-03273-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : DH | NIHR | Research for Patient Benefit Programme (NIHR Research for Patient Benefit Programme)
ID : NIHR201559
Organisme : DH | NIHR | Research for Patient Benefit Programme (NIHR Research for Patient Benefit Programme)
ID : NIHR201559
Organisme : DH | NIHR | Research for Patient Benefit Programme (NIHR Research for Patient Benefit Programme)
ID : NIHR201559
Organisme : DH | NIHR | Research for Patient Benefit Programme (NIHR Research for Patient Benefit Programme)
ID : NIHR201559
Organisme : DH | NIHR | Research for Patient Benefit Programme (NIHR Research for Patient Benefit Programme)
ID : NIHR201559
Organisme : DH | NIHR | Research for Patient Benefit Programme (NIHR Research for Patient Benefit Programme)
ID : NIHR201559
Organisme : DH | NIHR | Research for Patient Benefit Programme (NIHR Research for Patient Benefit Programme)
ID : NIHR201559
Organisme : DH | NIHR | Research for Patient Benefit Programme (NIHR Research for Patient Benefit Programme)
ID : NIHR201559
Organisme : DH | NIHR | Research for Patient Benefit Programme (NIHR Research for Patient Benefit Programme)
ID : NIHR201559
Organisme : DH | NIHR | Research for Patient Benefit Programme (NIHR Research for Patient Benefit Programme)
ID : NIHR201559
Organisme : DH | NIHR | Research for Patient Benefit Programme (NIHR Research for Patient Benefit Programme)
ID : NIHR201559
Organisme : DH | NIHR | Research for Patient Benefit Programme (NIHR Research for Patient Benefit Programme)
ID : NIHR201559
Organisme : DH | NIHR | Research for Patient Benefit Programme (NIHR Research for Patient Benefit Programme)
ID : NIHR201559

Informations de copyright

© 2024. The Author(s).

Références

Viswanathan P, Sagoo MS, Olver JM. UK national survey of enucleation, evisceration and orbital implant trends. Br J Ophthalmol. 2007;91:616–9.
doi: 10.1136/bjo.2006.103937 pubmed: 17151061
Song JS, Oh J, Baek SH. A survey of satisfaction in an ophthalmic patients wearing ocular prosthesis. Graefes Arch Clin Exp Ophthalmol. 2006;244:330–5.
doi: 10.1007/s00417-005-0037-0 pubmed: 16133031
Lubkin V, Sloan S. Enucleation and psychic trauma. Adv Ophthalmic Plast Reconstr Surg. 1990;8:259–62.
pubmed: 2248718
McBain HB, Ezra DG, Rose GE, Newman SP. The psychosocial impact of living with an ocular prosthesis. Orbit. 2014;33:39–44.
doi: 10.3109/01676830.2013.851251 pubmed: 24205995
Zoltie T, Bartlett P, Archer T, Walshaw E, Gout T. Digital photographic technique for the production of an artificial eye. J Vis Commun Med. 2021;44(Apr):41–4. https://doi.org/10.1080/17453054.2021.1882294 .
doi: 10.1080/17453054.2021.1882294 pubmed: 33596756
Cerullo L. Plastic artificial eyes: overview and technique. Adv Ophthalmic Plast Reconstr Surg. 1990;8:25–45.
pubmed: 2248717
Gout T, Zoltie T, Woodward A, Coleman E, Boele F, Chang B, et al. A cross-over, randomised feasibility study of digitally printed versus hand-painted artificial eyes in adults: PERSONAL-EYE-S - a study protocol [version 2; peer review: 2 approved]. NIHR Open Res. 2023;2:50.
doi: 10.3310/nihropenres.13311.2 pubmed: 37056714 pmcid: 7614426
Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, et al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ. 2016;355:i5239.
doi: 10.1136/bmj.i5239 pubmed: 27777223 pmcid: 5076380
Dwan K, Li T, Altman DG, Elbourne D. CONSORT 2010 statement: extension to randomised crossover trials. BMJ. 2019;366:l4378.
doi: 10.1136/bmj.l4378 pubmed: 31366597 pmcid: 6667942
Teare MD, Dimairio M, Shephard N, Hayman A, Whitehead A, Walters S. Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study. Trials 2014;15:264.
doi: 10.1186/1745-6215-15-264 pubmed: 24993581 pmcid: 4227298
Julious SA. Sample size of 12 per group rule of thumb for a pilot study. Pharm Stat. 2005;4:287–91.
doi: 10.1002/pst.185
Boele FW, Kawalek JC, Nicklin E, Gout T, Watson JM. on behalf of The PERSONAL-EYE-S Study Group. Living with an artificial eye: qualitative insights into patient and family member experiences. Int Ophthalmol. 2024;44:227. https://doi.org/10.1007/s10792-024-02933-0 .
doi: 10.1007/s10792-024-02933-0 pubmed: 38776029 pmcid: 11111535
INVOLVE. Briefing notes for researchers: involving the public in NHS, public health and social care research. Eastleigh: INVOLVE; 2012.

Auteurs

Amie Woodward (A)

York Trials Unit, Department of Health Sciences, University of York, York, UK.

Elizabeth Coleman (E)

York Trials Unit, Department of Health Sciences, University of York, York, UK.

Sarah Ronaldson (S)

York Trials Unit, Department of Health Sciences, University of York, York, UK.

Tim Zoltie (T)

School of Dentistry, Faculty of Medicine and Health, University of Leeds, Leeds, UK.

Paul Bartlett (P)

Maxillofacial Laboratory, Leeds Dental Institute, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Laura Wilson (L)

Leeds Artificial Eye Service, Leeds Dental Institute, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Tom Archer (T)

Leeds Artificial Eye Service, Leeds Dental Institute, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Jessica Kawalek (J)

Leeds Institute of Medical Research at St James's, St James's University Hospital, University of Leeds, Leeds, UK.

Florien Boele (F)

Leeds Institute of Medical Research at St James's, St James's University Hospital, University of Leeds, Leeds, UK.
Leeds Institute of Health Sciences, Faculty of Medicine and Health, University of Leeds, Leeds, UK.

Bernard Chang (B)

Department of Ophthalmology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

George Kalantzis (G)

Department of Ophthalmology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Mike Theaker (M)

Patient and Public Involvement representative, Leeds, UK.

Nabil El-Hindy (N)

Department of Ophthalmology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Emma Walshaw (E)

Leeds Artificial Eye Service, Leeds Dental Institute, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Taras Gout (T)

Leeds Artificial Eye Service, Leeds Dental Institute, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Department of Ophthalmology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Judith Watson (J)

York Trials Unit, Department of Health Sciences, University of York, York, UK. jude.watson@york.ac.uk.

Classifications MeSH